A randomized trial of chemotherapy (L-PAM vs CMF) and irradiation for node positive breast cancer Hyman B. MussM. Robert CooperCharles L. Spurr Report Pages: 77 - 84
Prognostic value of total cathepsin D in breast tumors Moïse NamerAlain RamaioliFrançoise Lapalus Report Pages: 85 - 93
Progestin treatment depresses estrogen receptor but not cathepsin D levels in needle aspirates of benign breast disease T. MaudelondeP. LavaudH. Rochefort Report Pages: 95 - 102
65 and 47 kDa forms of estrogen receptor in human breast cancer: relation with estrogen responsiveness Suzanne JozanAnne-Marie JuliaJean Frédéric David Report Pages: 103 - 109
Incidence of an estrogen receptor polymorphism in breast cancer patients Rita K. SchmutzlerMercedes SanchezBeth Schachter Report Pages: 111 - 117
Gastrin releasing peptide GRP(14–27) in human breast cancer cells and in small cell lung cancer A. J. VangstedE. V. AndersenJ. Zeuthen Report Pages: 119 - 128
Oral ondansetron (GR 38032F) for the control of CMF-induced emesis in the outpatient Elisabetta CamporaCristina OlivaRiccardo Rosso Brief Communication Pages: 129 - 132